Commensal Defense

Beneficial gut bacteria have evolved resistance to antimicrobial peptides that hosts release to fight pathogens.

Written byKate Yandell
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

INSTITUTE OF FOOD RESEARCH, KATHRYN CROSS AND NIKKI HORN

Mammalian hosts fight gut infections in part by releasing antimicrobial peptides that disrupt bacterial membranes. But it has been unclear how beneficial microbes survive the release of these peptides and maintain stable populations in the gut. One major group of commensal gut bacteria, the Bacteroidetes, avoids becoming collateral damage with just one gene, which encodes an enzyme that modifies lipopolysaccharides (LPS) in their cell membranes, according to a paper published today (January 8) in Science.

“Many aspects of the immune response target microbial features generally, not specific factors that only are found on pathogens,” said study coauthor Andy Goodman, an assistant professor in the department of microbial pathogenesis at Yale University School of Medicine. “We didn’t understand how you could have a host response that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies